Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M21.1Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-4.6
Enterprise Value $M1.6EPS (TTM) $-1.3Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yY
Price/Book1.110-y EBITDA Growth Rate %--Quick Ratio6.3Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %18.6Current Ratio6.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-81.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-96.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M20.9ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ONCS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ONCS is held by these investors:



ONCS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Mohan-Peterson SheelaChief Legal&Compliance Officer 2017-01-31Buy3,000$0.99-7.07view
DHILLON PUNITPresident and CEO 2017-01-31Buy3,000$0.99-7.07view
DHILLON PUNITPresident and CEO 2016-07-31Buy3,000$1.44-36.11view
Mohan-Peterson SheelaCL&CO 2016-07-31Buy3,000$1.44-36.11view
DHILLON AVTAR SDirector 2015-10-16Buy10,000$4.36-78.9view
Mohan-Peterson SheelaChief Legal Officer 2015-10-16Buy520$4.24-78.3view
DHILLON PUNITPresident and CEO 2015-10-16Buy10,000$4.25-78.35view
SLANSKY RICHARD BCFO 2015-07-06Buy150,000$6.12-84.97view
DHILLON PUNITPresident and CEO 2015-06-10Buy2,500$6.74-86.35view
MAIDA ANTHONY E IIIDirector 2014-03-20Buy1,140$16.2-94.32view

Press Releases about ONCS :

Quarterly/Annual Reports about ONCS:

News about ONCS:

Articles On GuruFocus.com
OncoSec to Host Third Quarter Financial Conference Call on June 1, 2017 May 11 2017 
Merck Collaborates With OncoSec Medical to Unlock Untapped Market for Keytruda May 10 2017 
OncoSec Announces Clinical Collaboration with Merck to Evaluate Combination of ImmunoPulse® IL-12 a May 10 2017 
OncoSec to Present at Biomarkers & Immuno-Oncology World Congress 2017 May 02 2017 
Heat Biologics Presents New Preclinical Data from OncoSec Collaboration at the American Association Apr 05 2017 
OncoSec Presents Preclinical Data Demonstrating Improved Systemic Anti-Tumor Response Following Modi Apr 03 2017 
Vista Partners Initiates Coverage on OncoSec Medical (Ticker: ONCS); Price Target $1.20 Jan 13 2015 

More From Other Websites
OncoSec to Host Third Quarter Financial Conference Call on June 1, 2017 May 11 2017
OncoSec Announces Clinical Collaboration with Merck to Evaluate Combination of ImmunoPulse® IL-12... May 10 2017
OncoSec to Present at Biomarkers & Immuno-Oncology World Congress 2017 May 02 2017
OncoSec collaboration data 'promising' for embattled Heat Bio Apr 12 2017
For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1 Apr 11 2017
Heat Biologics Presents New Preclinical Data from OncoSec Collaboration at the American Association... Apr 05 2017
OncoSec Presents Preclinical Data Demonstrating Improved Systemic Anti-Tumor Response Following... Apr 03 2017
OncoSec to Present Preclinical Data at the American Association for Cancer Research (AACR) Annual... Mar 28 2017
OncoSec Medical's Intratumoral Plasmid IL-12 Demonstrates Effectiveness at Enhancing Tumor... Mar 21 2017
OncoSec Announces First Technology Access Program Agreement with Inhibrx Mar 14 2017
OncoSec to Present at Scientific and Investment Conferences in March Mar 07 2017
Biotech Stock Mailbag: OncoSec Medical and the Quest to Turn Cold Tumors Hot Mar 03 2017
OncoSec to Host Second Quarter Financial Conference Call on March 16, 2017 Mar 02 2017
OncoSec Granted FDA Fast Track Designation for ImmunoPulse® IL-12 for the Treatment of Metastatic... Feb 27 2017
OncoSec to Host KOL Event Focused on New ASCO-SITC Melanoma Data and Clinical Strategy on Tuesday,... Feb 24 2017
OncoSec Announces Positive Phase II Data Demonstrating Company's ImmunoPulse® IL-12 in Combination... Feb 23 2017
OncoSec to Present New Clinical Data from Phase 2 Combination Study at ASCO-SITC Clinical... Feb 08 2017
OncoSec to Present at NobleCon13 Jan 26 2017
OncoSec to Present at Investment Conferences in January Jan 03 2017
LifeSci Capital Initiates Coverage of OncoSec Medical Dec 27 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}